Massachusetts General Hospital ( Site 4003) is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Massachusetts General Hospital ( Site 4003) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease.
Sponsors: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Massachusetts General Hospital ( Site 4003) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massachusetts General Hospital ( Site 4003) has 1 clinical trials on record, with 1 currently active. Their work covers Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease.
Massachusetts General Hospital ( Site 4003) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.